<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="/allregs/css/uswds.min.css">
    <link rel="stylesheet" href="/allregs/css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/allregs/index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/allregs/index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/parts/21CFR812.html">Part 812
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 812.43  Selecting investigators and monitors.
                            </h3>
                            <p class="depth1"><em>(a)</em> Selecting investigators. A sponsor shall select investigators qualified by training and experience to investigate the device.</p><p class="depth1"><em>(b)</em> Control of device. A sponsor shall ship investigational devices only to qualified investigators participating in the investigation.</p><p class="depth1"><em>(c)</em> Obtaining agreements. A sponsor shall obtain from each participating investigator a signed agreement that includes:</p><p class="depth2"><em>(1)</em> The investigator's curriculum vitae.</p><p class="depth2"><em>(2)</em> Where applicable, a statement of the investigator's relevant experience, including the dates, location, extent, and type of experience.</p><p class="depth2"><em>(3)</em> If the investigator was involved in an investigation or other research that was terminated, an explanation of the circumstances that led to termination.</p><p class="depth2"><em>(4)</em> A statement of the investigator's commitment to:</p><p class="depth3"><em>(i)</em> Conduct the investigation in accordance with the agreement, the investigational plan, this part and other applicable FDA regulations, and conditions of approval imposed by the reviewing IRB or FDA;</p><p class="depth3"><em>(ii)</em> Supervise all testing of the device involving human subjects; and</p><p class="depth3"><em>(iii)</em> Ensure that the requirements for obtaining informed consent are met.</p><p class="depth2"><em>(5)</em> Sufficient accurate financial disclosure information to allow the sponsor to submit a complete and accurate certification or disclosure statement as required under part 54 of this chapter.

The sponsor shall obtain a commitment from the clinical investigator to promptly update this information if any relevant changes occur during the course of the investigation and for 1 year following completion of the study. This information shall not be submitted in an investigational device exemption application, but shall be submitted in any marketing application involving the device.</p><p class="depth1"><em>(d)</em> Selecting monitors. A sponsor shall select monitors qualified by training and experience to monitor the investigational study in accordance with this part and other applicable FDA regulations.
[45 FR 3751, Jan. 18, 1980, as amended at 63 FR 5253, Feb. 2, 1998]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§.
          Code available <a href="https://github.com/anthonygarvan/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5
      </div>
    </div>
  </footer>
  </body>
</html>
